Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Steviol Glycoside Market by Type (Stevioside) and by End Use Industry (Beverage): Global Opportunity Analysis and Industry Forecast, 2023-2032

A08676

Pages: NA

Charts: NA

Tables: NA

Steviol Glycoside Market Analysis

Steviol glycoside is a chemical compound that imparts a sweet taste to leaves of the plant Stevia rebaudiana, a local South American plant and structures the primary component segment of a variety of sugars sold under the generic name stevia. Commercially, stevia is a white powder composed of one or more extremely sweet glycosides derived from leaves of stevia; it finds usage as a non-caloric sweetener. Steviol glycoside is about 30 and 320 times sweeter than sucrose. Sucrose refers to common sugar composed of two monosaccharaides: glucose and fructose. Steviol are constant in heat, pH-stable, ferment, when ingested they do not induce a glycemic response, consequently, making them good options as sugar substitutes for people suffering from diabetes and other people who need to control carbohydrates in their diet. Many food & beverage companies use stevia as a natural sweetener to make products with improved taste and less total calories. Steviol glycoside stimulates insulin secretion and prevents high blood glucose after a meal.

COVID-19 scenario analysis:

  • The global market for Steviol glycosides is severely impacted by the outbreak of the COVID-19 pandemic. 
  • The COVID-19 pandemic led to a decline in the economic growth in almost all major countries, thus affecting consumer spending patterns. 
  • Owing to the lockdown implemented across various countries, national and international transport have been hampered, which has significantly impacted the supply chain of numerous industries across the globe, thereby increasing the supply–demand gap.
  • Thus, insufficiency in raw material supply is expected to hamper the production rate of Steviol glycosides, which negatively impact the market growth. 

Top impacting factors: Market Scenario Analysis, Trends, Drivers, and Impact Analysis

The steviol glycoside market has improved performance because of the huge interest for artificial sweeteners. It's a safe choice for diabetes patients. The increasing demand from food makers, for example, products as fruits and milk-based beverages, yoghurts and treats as far as artificial sugars drives the steviol glycoside market. This helps in retaining pleasantness for longer than sugar. Steviol glycoside is exceptionally popular in the market since customers are progressively disposed toward safe and quick intake of food synthetic or ingredients.

Its adverse effects on infants as a sugar substitute restrain growth of the Steviol glycoside market during the forecast period. In some cases, Steviol can cause a severe allergic reaction called anaphylaxis, though this occurs rarely.Symptoms of allergic reactions are, hives dizziness, wheezing, shortness of breath, general weakness or having difficulty in swallowing shortly after intake of steviol glycoside.

New product launches to flourish the market

Cargill Incorporated and Koninklijke DSM N.V. declared collaboration effort for the development of sweet tasting chemicals for use in food and beverage, pharmaceutical market, for example, steviol glycosides Rebaudioside M and Rebaudioside D by fermentation process resulting in larger quantities of the compounds as compared to the traditional methods giving food and beverage manufacturers an even more scalable, sustainable and low cost solution than if these same molecules were extracted from the stevia leaf. 

Surge in use in industrial applications

Steviol glycoside is leading in food and beverage industry and serving it. Due to low calorie feature customer demands are increasing. Stevia is utilized as a substitute for sugar to add characteristic sweetness to hot or cold beverages, to be sprinkled on natural items, or for use in cooking. Stevi is a wellspring of pleasantness, which is 200–300 times better than sugar and is reasonable for diabetics and individuals experiencing phenylketonuria. Natuvia by PureCircle, SteviaFirst Corp and Truvia are some of the commonly referred to brands of stevia as a tabletop sweetener. Mainly it is utilized in beverages such as diet carbonated drinks, flavored water, soft drinks, fruit juices, ready-to-drink beverages, and sports & energy drinks. 

Key benefits of the report:

  • This study presents the analytical depiction of the global Steviol Glycoside industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global steviol glycoside market.
  • The current market is quantitatively analyzed highlight the global steviol glycoside market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed global steviol glycoside market analysis based on competitive intensity and how the competition will take shape in coming years. 

Questions answered in the steviol glycoside market research report:

  • Who are the leading market players active in the steviol glycoside market?
  • What would be the detailed impact of COVID-19 on the market?
  • What current trends would influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the steviol glycoside market?
  • What are the projections for the future that would help in taking further strategic steps?

Key Market Segments

  • By Type
    • Stevioside
      • Rebaudioside A
      • Rebaudioside C
      • Dulcoside A
      • Other
  • By End Use Industry
    • Beverage
      • Food
      • Medicine
      • Chemicals
      • Paints & Coatings
      • Personal Care
  • By Region
    • North America
      • US
      • Canada
    • Europe
      • Germany
      • UK
      • France
      • rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • rest of LAMEA


Key Market Players

  • Zydus
  • PureCircle
  • Merisant
  • Sunrise Nutrachem Group
  • Tate & Lyle
  • GL Stevia
  • Daepyung
  • Ingredion, Inc.
  • Morita Kagaku Kogyo
  • Cargill
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: STEVIOL GLYCOSIDE MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Stevioside

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

      • 4.2.4. Rebaudioside A

        • 4.2.4.1. Market Size and Forecast
      • 4.2.4. Rebaudioside C

        • 4.2.4.1. Market Size and Forecast
      • 4.2.4. Dulcoside A

        • 4.2.4.1. Market Size and Forecast
      • 4.2.4. Other

        • 4.2.4.1. Market Size and Forecast
  • CHAPTER 5: STEVIOL GLYCOSIDE MARKET, BY END USE INDUSTRY

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By End Use Industry

    • 5.2. Beverage

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

      • 5.2.4. Food

        • 5.2.4.1. Market Size and Forecast
      • 5.2.4. Medicine

        • 5.2.4.1. Market Size and Forecast
      • 5.2.4. Chemicals

        • 5.2.4.1. Market Size and Forecast
      • 5.2.4. Paints and Coatings

        • 5.2.4.1. Market Size and Forecast
      • 5.2.4. Personal Care

        • 5.2.4.1. Market Size and Forecast
  • CHAPTER 6: STEVIOL GLYCOSIDE MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Type

      • 6.2.3. Market Size and Forecast, By End Use Industry

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Steviol Glycoside Market

        • 6.2.5.1. Market Size and Forecast, By Type
        • 6.2.5.2. Market Size and Forecast, By End Use Industry
      • 6.2.6. Canada Steviol Glycoside Market

        • 6.2.6.1. Market Size and Forecast, By Type
        • 6.2.6.2. Market Size and Forecast, By End Use Industry
      • 6.2.7. Mexico Steviol Glycoside Market

        • 6.2.7.1. Market Size and Forecast, By Type
        • 6.2.7.2. Market Size and Forecast, By End Use Industry
    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Type

      • 6.3.3. Market Size and Forecast, By End Use Industry

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Steviol Glycoside Market

        • 6.3.5.1. Market Size and Forecast, By Type
        • 6.3.5.2. Market Size and Forecast, By End Use Industry
      • 6.3.6. Germany Steviol Glycoside Market

        • 6.3.6.1. Market Size and Forecast, By Type
        • 6.3.6.2. Market Size and Forecast, By End Use Industry
      • 6.3.7. Italy Steviol Glycoside Market

        • 6.3.7.1. Market Size and Forecast, By Type
        • 6.3.7.2. Market Size and Forecast, By End Use Industry
      • 6.3.8. Spain Steviol Glycoside Market

        • 6.3.8.1. Market Size and Forecast, By Type
        • 6.3.8.2. Market Size and Forecast, By End Use Industry
      • 6.3.9. UK Steviol Glycoside Market

        • 6.3.9.1. Market Size and Forecast, By Type
        • 6.3.9.2. Market Size and Forecast, By End Use Industry
      • 6.3.10. Russia Steviol Glycoside Market

        • 6.3.10.1. Market Size and Forecast, By Type
        • 6.3.10.2. Market Size and Forecast, By End Use Industry
      • 6.3.11. Rest Of Europe Steviol Glycoside Market

        • 6.3.11.1. Market Size and Forecast, By Type
        • 6.3.11.2. Market Size and Forecast, By End Use Industry
    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Type

      • 6.4.3. Market Size and Forecast, By End Use Industry

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Steviol Glycoside Market

        • 6.4.5.1. Market Size and Forecast, By Type
        • 6.4.5.2. Market Size and Forecast, By End Use Industry
      • 6.4.6. Japan Steviol Glycoside Market

        • 6.4.6.1. Market Size and Forecast, By Type
        • 6.4.6.2. Market Size and Forecast, By End Use Industry
      • 6.4.7. India Steviol Glycoside Market

        • 6.4.7.1. Market Size and Forecast, By Type
        • 6.4.7.2. Market Size and Forecast, By End Use Industry
      • 6.4.8. South Korea Steviol Glycoside Market

        • 6.4.8.1. Market Size and Forecast, By Type
        • 6.4.8.2. Market Size and Forecast, By End Use Industry
      • 6.4.9. Australia Steviol Glycoside Market

        • 6.4.9.1. Market Size and Forecast, By Type
        • 6.4.9.2. Market Size and Forecast, By End Use Industry
      • 6.4.10. Thailand Steviol Glycoside Market

        • 6.4.10.1. Market Size and Forecast, By Type
        • 6.4.10.2. Market Size and Forecast, By End Use Industry
      • 6.4.11. Malaysia Steviol Glycoside Market

        • 6.4.11.1. Market Size and Forecast, By Type
        • 6.4.11.2. Market Size and Forecast, By End Use Industry
      • 6.4.12. Indonesia Steviol Glycoside Market

        • 6.4.12.1. Market Size and Forecast, By Type
        • 6.4.12.2. Market Size and Forecast, By End Use Industry
      • 6.4.13. Rest of Asia Pacific Steviol Glycoside Market

        • 6.4.13.1. Market Size and Forecast, By Type
        • 6.4.13.2. Market Size and Forecast, By End Use Industry
    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Type

      • 6.5.3. Market Size and Forecast, By End Use Industry

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Steviol Glycoside Market

        • 6.5.5.1. Market Size and Forecast, By Type
        • 6.5.5.2. Market Size and Forecast, By End Use Industry
      • 6.5.6. South Africa Steviol Glycoside Market

        • 6.5.6.1. Market Size and Forecast, By Type
        • 6.5.6.2. Market Size and Forecast, By End Use Industry
      • 6.5.7. Saudi Arabia Steviol Glycoside Market

        • 6.5.7.1. Market Size and Forecast, By Type
        • 6.5.7.2. Market Size and Forecast, By End Use Industry
      • 6.5.8. UAE Steviol Glycoside Market

        • 6.5.8.1. Market Size and Forecast, By Type
        • 6.5.8.2. Market Size and Forecast, By End Use Industry
      • 6.5.9. Argentina Steviol Glycoside Market

        • 6.5.9.1. Market Size and Forecast, By Type
        • 6.5.9.2. Market Size and Forecast, By End Use Industry
      • 6.5.10. Rest of LAMEA Steviol Glycoside Market

        • 6.5.10.1. Market Size and Forecast, By Type
        • 6.5.10.2. Market Size and Forecast, By End Use Industry
  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Cargill

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Zydus

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Merisant

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. GL Stevia

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. PureCircle

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Sunrise Nutrachem Group

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Daepyung

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Ingredion, Inc.

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Morita Kagaku Kogyo

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Tate And Lyle

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL STEVIOL GLYCOSIDE MARKET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL STEVIOL GLYCOSIDE MARKET FOR STEVIOSIDE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL STEVIOL GLYCOSIDE MARKET, BY END USE INDUSTRY, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL STEVIOL GLYCOSIDE MARKET FOR BEVERAGE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL STEVIOL GLYCOSIDE MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. NORTH AMERICA STEVIOL GLYCOSIDE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. NORTH AMERICA STEVIOL GLYCOSIDE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 8. NORTH AMERICA STEVIOL GLYCOSIDE, BY END USE INDUSTRY, 2025-2033 ($MILLION)
  • TABLE 9. U.S. STEVIOL GLYCOSIDE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 10. U.S. STEVIOL GLYCOSIDE, BY END USE INDUSTRY, 2025-2033 ($MILLION)
  • TABLE 11. CANADA STEVIOL GLYCOSIDE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 12. CANADA STEVIOL GLYCOSIDE, BY END USE INDUSTRY, 2025-2033 ($MILLION)
  • TABLE 13. MEXICO STEVIOL GLYCOSIDE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 14. MEXICO STEVIOL GLYCOSIDE, BY END USE INDUSTRY, 2025-2033 ($MILLION)
  • TABLE 15. EUROPE STEVIOL GLYCOSIDE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. EUROPE STEVIOL GLYCOSIDE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 17. EUROPE STEVIOL GLYCOSIDE, BY END USE INDUSTRY, 2025-2033 ($MILLION)
  • TABLE 18. FRANCE STEVIOL GLYCOSIDE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 19. FRANCE STEVIOL GLYCOSIDE, BY END USE INDUSTRY, 2025-2033 ($MILLION)
  • TABLE 20. GERMANY STEVIOL GLYCOSIDE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 21. GERMANY STEVIOL GLYCOSIDE, BY END USE INDUSTRY, 2025-2033 ($MILLION)
  • TABLE 22. ITALY STEVIOL GLYCOSIDE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 23. ITALY STEVIOL GLYCOSIDE, BY END USE INDUSTRY, 2025-2033 ($MILLION)
  • TABLE 24. SPAIN STEVIOL GLYCOSIDE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 25. SPAIN STEVIOL GLYCOSIDE, BY END USE INDUSTRY, 2025-2033 ($MILLION)
  • TABLE 26. UK STEVIOL GLYCOSIDE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 27. UK STEVIOL GLYCOSIDE, BY END USE INDUSTRY, 2025-2033 ($MILLION)
  • TABLE 28. RUSSIA STEVIOL GLYCOSIDE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 29. RUSSIA STEVIOL GLYCOSIDE, BY END USE INDUSTRY, 2025-2033 ($MILLION)
  • TABLE 30. REST OF EUROPE STEVIOL GLYCOSIDE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 31. REST OF EUROPE STEVIOL GLYCOSIDE, BY END USE INDUSTRY, 2025-2033 ($MILLION)
  • TABLE 32. ASIA-PACIFIC STEVIOL GLYCOSIDE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 33. ASIA-PACIFIC STEVIOL GLYCOSIDE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 34. ASIA-PACIFIC STEVIOL GLYCOSIDE, BY END USE INDUSTRY, 2025-2033 ($MILLION)
  • TABLE 35. CHINA STEVIOL GLYCOSIDE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 36. CHINA STEVIOL GLYCOSIDE, BY END USE INDUSTRY, 2025-2033 ($MILLION)
  • TABLE 37. JAPAN STEVIOL GLYCOSIDE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 38. JAPAN STEVIOL GLYCOSIDE, BY END USE INDUSTRY, 2025-2033 ($MILLION)
  • TABLE 39. INDIA STEVIOL GLYCOSIDE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 40. INDIA STEVIOL GLYCOSIDE, BY END USE INDUSTRY, 2025-2033 ($MILLION)
  • TABLE 41. SOUTH KOREA STEVIOL GLYCOSIDE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 42. SOUTH KOREA STEVIOL GLYCOSIDE, BY END USE INDUSTRY, 2025-2033 ($MILLION)
  • TABLE 43. AUSTRALIA STEVIOL GLYCOSIDE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 44. AUSTRALIA STEVIOL GLYCOSIDE, BY END USE INDUSTRY, 2025-2033 ($MILLION)
  • TABLE 45. THAILAND STEVIOL GLYCOSIDE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 46. THAILAND STEVIOL GLYCOSIDE, BY END USE INDUSTRY, 2025-2033 ($MILLION)
  • TABLE 47. MALAYSIA STEVIOL GLYCOSIDE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 48. MALAYSIA STEVIOL GLYCOSIDE, BY END USE INDUSTRY, 2025-2033 ($MILLION)
  • TABLE 49. INDONESIA STEVIOL GLYCOSIDE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 50. INDONESIA STEVIOL GLYCOSIDE, BY END USE INDUSTRY, 2025-2033 ($MILLION)
  • TABLE 51. REST OF ASIA PACIFIC STEVIOL GLYCOSIDE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 52. REST OF ASIA PACIFIC STEVIOL GLYCOSIDE, BY END USE INDUSTRY, 2025-2033 ($MILLION)
  • TABLE 53. LAMEA STEVIOL GLYCOSIDE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 54. LAMEA STEVIOL GLYCOSIDE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 55. LAMEA STEVIOL GLYCOSIDE, BY END USE INDUSTRY, 2025-2033 ($MILLION)
  • TABLE 56. BRAZIL STEVIOL GLYCOSIDE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 57. BRAZIL STEVIOL GLYCOSIDE, BY END USE INDUSTRY, 2025-2033 ($MILLION)
  • TABLE 58. SOUTH AFRICA STEVIOL GLYCOSIDE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 59. SOUTH AFRICA STEVIOL GLYCOSIDE, BY END USE INDUSTRY, 2025-2033 ($MILLION)
  • TABLE 60. SAUDI ARABIA STEVIOL GLYCOSIDE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 61. SAUDI ARABIA STEVIOL GLYCOSIDE, BY END USE INDUSTRY, 2025-2033 ($MILLION)
  • TABLE 62. UAE STEVIOL GLYCOSIDE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 63. UAE STEVIOL GLYCOSIDE, BY END USE INDUSTRY, 2025-2033 ($MILLION)
  • TABLE 64. ARGENTINA STEVIOL GLYCOSIDE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 65. ARGENTINA STEVIOL GLYCOSIDE, BY END USE INDUSTRY, 2025-2033 ($MILLION)
  • TABLE 66. REST OF LAMEA STEVIOL GLYCOSIDE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 67. REST OF LAMEA STEVIOL GLYCOSIDE, BY END USE INDUSTRY, 2025-2033 ($MILLION)
  • TABLE 68. CARGILL: KEY EXECUTIVES
  • TABLE 69. CARGILL: COMPANY SNAPSHOT
  • TABLE 70. CARGILL: OPERATING SEGMENTS
  • TABLE 71. CARGILL: PRODUCT PORTFOLIO
  • TABLE 72. CARGILL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 73. ZYDUS: KEY EXECUTIVES
  • TABLE 74. ZYDUS: COMPANY SNAPSHOT
  • TABLE 75. ZYDUS: OPERATING SEGMENTS
  • TABLE 76. ZYDUS: PRODUCT PORTFOLIO
  • TABLE 77. ZYDUS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 78. MERISANT: KEY EXECUTIVES
  • TABLE 79. MERISANT: COMPANY SNAPSHOT
  • TABLE 80. MERISANT: OPERATING SEGMENTS
  • TABLE 81. MERISANT: PRODUCT PORTFOLIO
  • TABLE 82. MERISANT: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 83. GL STEVIA: KEY EXECUTIVES
  • TABLE 84. GL STEVIA: COMPANY SNAPSHOT
  • TABLE 85. GL STEVIA: OPERATING SEGMENTS
  • TABLE 86. GL STEVIA: PRODUCT PORTFOLIO
  • TABLE 87. GL STEVIA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 88. PURECIRCLE: KEY EXECUTIVES
  • TABLE 89. PURECIRCLE: COMPANY SNAPSHOT
  • TABLE 90. PURECIRCLE: OPERATING SEGMENTS
  • TABLE 91. PURECIRCLE: PRODUCT PORTFOLIO
  • TABLE 92. PURECIRCLE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 93. SUNRISE NUTRACHEM GROUP: KEY EXECUTIVES
  • TABLE 94. SUNRISE NUTRACHEM GROUP: COMPANY SNAPSHOT
  • TABLE 95. SUNRISE NUTRACHEM GROUP: OPERATING SEGMENTS
  • TABLE 96. SUNRISE NUTRACHEM GROUP: PRODUCT PORTFOLIO
  • TABLE 97. SUNRISE NUTRACHEM GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 98. DAEPYUNG: KEY EXECUTIVES
  • TABLE 99. DAEPYUNG: COMPANY SNAPSHOT
  • TABLE 100. DAEPYUNG: OPERATING SEGMENTS
  • TABLE 101. DAEPYUNG: PRODUCT PORTFOLIO
  • TABLE 102. DAEPYUNG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 103. INGREDION, INC.: KEY EXECUTIVES
  • TABLE 104. INGREDION, INC.: COMPANY SNAPSHOT
  • TABLE 105. INGREDION, INC.: OPERATING SEGMENTS
  • TABLE 106. INGREDION, INC.: PRODUCT PORTFOLIO
  • TABLE 107. INGREDION, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 108. MORITA KAGAKU KOGYO: KEY EXECUTIVES
  • TABLE 109. MORITA KAGAKU KOGYO: COMPANY SNAPSHOT
  • TABLE 110. MORITA KAGAKU KOGYO: OPERATING SEGMENTS
  • TABLE 111. MORITA KAGAKU KOGYO: PRODUCT PORTFOLIO
  • TABLE 112. MORITA KAGAKU KOGYO: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 113. TATE AND LYLE: KEY EXECUTIVES
  • TABLE 114. TATE AND LYLE: COMPANY SNAPSHOT
  • TABLE 115. TATE AND LYLE: OPERATING SEGMENTS
  • TABLE 116. TATE AND LYLE: PRODUCT PORTFOLIO
  • TABLE 117. TATE AND LYLE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL STEVIOL GLYCOSIDE MARKET SEGMENTATION
  • FIGURE 2. GLOBAL STEVIOL GLYCOSIDE MARKET
  • FIGURE 3. SEGMENTATION STEVIOL GLYCOSIDE MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN STEVIOL GLYCOSIDE MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALSTEVIOL GLYCOSIDE MARKET
  • FIGURE 11. STEVIOL GLYCOSIDE MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. STEVIOL GLYCOSIDE MARKET FOR STEVIOSIDE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. STEVIOL GLYCOSIDE MARKET SEGMENTATION, BY BY END USE INDUSTRY
  • FIGURE 14. STEVIOL GLYCOSIDE MARKET FOR BEVERAGE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 16. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 17. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 18. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 19. COMPETITIVE DASHBOARD
  • FIGURE 20. COMPETITIVE HEATMAP: STEVIOL GLYCOSIDE MARKET
  • FIGURE 21. TOP PLAYER POSITIONING, 2024
  • FIGURE 22. CARGILL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 23. CARGILL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 24. CARGILL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 25. ZYDUS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 26. ZYDUS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 27. ZYDUS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 28. MERISANT: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 29. MERISANT: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 30. MERISANT: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 31. GL STEVIA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 32. GL STEVIA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 33. GL STEVIA: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 34. PURECIRCLE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 35. PURECIRCLE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 36. PURECIRCLE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 37. SUNRISE NUTRACHEM GROUP: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 38. SUNRISE NUTRACHEM GROUP: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 39. SUNRISE NUTRACHEM GROUP: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 40. DAEPYUNG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 41. DAEPYUNG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 42. DAEPYUNG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 43. INGREDION, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 44. INGREDION, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 45. INGREDION, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 46. MORITA KAGAKU KOGYO: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 47. MORITA KAGAKU KOGYO: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 48. MORITA KAGAKU KOGYO: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 49. TATE AND LYLE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 50. TATE AND LYLE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 51. TATE AND LYLE: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Steviol Glycoside Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue